Pharmaceutical companies are backing away from a growing threat that could kill 10 million people a year by 2050

Novartis last week joined a number of large pharma companies that are dropping their antibiotics research projects. As superbugs become a growing problem, here's a look at what drugmakers have in store to combat this issue.

https://www.businessinsider.com/major-pharmaceutical-companies-dropping-antibiotic-projects-superbugs-2018-7?r=US&IR=T

About Robert Zinn

Robert Zinn, M.D., Ph.D. is a medical doctor, physician, and web entrepreneur, who, for over 15 years was employed by academic and research institutions and focused his clinical practices on very specialized patient populations, such as those with rare genetic diseases or rare cancers. He shares his knowledge through his website, NutritionTheory.org

View all posts by Robert Zinn →